Levofloxacin Kabi

Levofloxacin, the active ingredient in Levofloxacin Kabi, is a fluoroquinolone antibiotic presented as a solution for injection for intravenous use. It treats susceptible bacterial infections such as community‑acquired pneumonia, complicated urinary tract infections, intra‑abdominal infections, skin and soft tissue infections, and other infections caused by susceptible bacteria.

GNH USA supplies Levofloxacin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Levofloxacin is a fluoroquinolone antibiotic used to treat infections caused by susceptible bacteria. - Community‑acquired pneumonia: effective treatment of susceptible strains, improving clinical outcomes. - Complicated urinary tract infections: eradicates causative bacteria, facilitating resolution of infection. - Complicated intra‑abdominal infections: provides antibacterial coverage against Gram‑negative and some Gram‑positive organisms. - Skin and soft tissue infections: treats susceptible bacterial skin infections, aiding recovery. - Other infections caused by susceptible bacteria: addresses various infections where the pathogen is known to be sensitive.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Elevated liver enzymes: mild hepatic enzyme changes.

Serious or Rare Side Effects: - Tendon rupture: risk of tendonitis or rupture, especially in older adults. - QT prolongation: potential cardiac arrhythmia. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis. - Central nervous system effects: seizures or psychosis.

Before using Levofloxacin, consider the following precautions to minimize risk. - Renal impairment: adjust therapy and monitor renal function. - History of tendon disorders: avoid use in patients with prior tendonitis or rupture. - Cardiac risk: assess QT interval and avoid in patients with known prolongation. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Concomitant CNS active drugs: monitor for increased neuropsychiatric effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption, separate dosing by at least 2 hours. - Warfarin: may increase INR, monitor coagulation. - Cyclosporine: increased cyclosporine levels, monitor concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened risk of CNS stimulation or seizures. - Theophylline: increased plasma levels, watch for toxicity. - Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycemia, monitor glucose.